3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Brain Neoplasms
2
Meningeal Neoplasms
1
Breast Neoplasms
1
Interventions
Trastuzumab
2
Radiotherapy
2
Capecitabine
2
tucatinib
1
sapanisertib
1
pertuzumab
1
patritumab deruxtecan
1
paclitaxel-Angiopep-2 conjugate
1
omburtamab I-131
1
fludarabine
1
eribulin
1
avelumab
1
WP 744
1
Temozolomide
1
Spinal Puncture
1
Rituximab
1
Psychiatric Rehabilitation
1
Phlebotomy
1
Methotrexate
1
Cyclophosphamide
1
Amplified Fragment Length Polymorphism Analysis
1
AZD1390
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Meningeal Neoplasms
×
patritumab deruxtecan
×
CNS
×
Clear all
NCT05865990
2026-05-04
TUXEDO-3
MedSIR
Phase 2
Completed
63 enrolled